XML 57 R16.htm IDEA: XBRL DOCUMENT

Goodwill	12 Months Ended
Goodwill	Dec. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Goodwill In December 2017, the Company expanded its activities in the field of infectious diseases with the acquisition of Discuva Limited, a privately held United Kingdom-based company. Through this acquisition, the Company obtained a bacterial genetics platform and a suite of software-based technologies, which facilitates the discovery and development of new mechanism antibiotics. This resulted in the recognition of goodwill of £1.5 million, which is translated into U.S. dollars at each reporting period. As of December 31, 2025 and 2024, goodwill was $2,001 and $1,864, respectively. Changes year over year are the result of changes in foreign currency. The Company assesses goodwill for impairment on an annual basis as of December 31 or more frequently when events and circumstances occur indicating that recorded goodwill may be impaired. As of December 31, 2025, the Company performed its annual impairment assessment of goodwill and determined that it is more likely than not that the fair value of the reporting unit exceeds its carrying amount. The Company has recorded no goodwill impairment charges to date.